Basic Information
| LncRNA/CircRNA Name | ASO3690 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | Microarray, qPCR |
| Sample | lung adenocarcinoma tissues |
| Expression Pattern | down-regulated |
| Function Description | There are significant differences in the lncRNA expression profiles in Chinese patients with pulmonary adenocarcinoma. LncRNAs such as AK124939 may be anticancer factors related to the progression of pulmonary adenocarcinoma |
| Pubmed ID | 25061321 |
| Year | 2014 |
| Title | Expression profiles and initial confirmation of long noncoding RNAs in Chinese patients with pulmonary adenocarcinoma |
External Links
| Links for ASO3690 | GenBank HGNC NONCODE |
| Links for lung adenocarcinoma | OMIM COSMIC |